FI111382B - Förfaranden för åstadkommande av antigastrit-substans och biologiskt ren odling av en mjölksyrabakteriestam samt förfaranden för framställning av livsmedelssammansättning och läkemedelssammansättning - Google Patents

Förfaranden för åstadkommande av antigastrit-substans och biologiskt ren odling av en mjölksyrabakteriestam samt förfaranden för framställning av livsmedelssammansättning och läkemedelssammansättning Download PDF

Info

Publication number
FI111382B
FI111382B FI933001A FI933001A FI111382B FI 111382 B FI111382 B FI 111382B FI 933001 A FI933001 A FI 933001A FI 933001 A FI933001 A FI 933001A FI 111382 B FI111382 B FI 111382B
Authority
FI
Finland
Prior art keywords
substance
lactic acid
acid bacterial
culture
antigastrite
Prior art date
Application number
FI933001A
Other languages
English (en)
Finnish (fi)
Other versions
FI933001A (fi
FI933001A0 (fi
Inventor
Jean-Richard Neeser
Dominique Brassart
Pierre Michetti
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8211947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI111382(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of FI933001A0 publication Critical patent/FI933001A0/fi
Publication of FI933001A publication Critical patent/FI933001A/fi
Application granted granted Critical
Publication of FI111382B publication Critical patent/FI111382B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Treating Waste Gases (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)

Claims (9)

1. Förfarande för att ästadkomma en biologiskt ren odling av en mjölksyrabakteriestam, kännetecknat av, att en Lactobacillus johnsonii-stam CNCM 5 1-1225 väljs som nämnda mjölksyrabakterie, och att Lactobacillus johnsonii CNCM 1-1225 därefter odlas och isoleras.
2. Förfarande för att ästadkomma en antigastrit-substans och/eller en magsärsmotverkande substans, kännetecknat av, att antigastrit-substansen 10 och/eller den magsärsmotverkande substansen framställs genom att odla en biologiskt ren Lactobacillus johnsonii - stam CNCM 1-1225, som valts för att den har förmägan att producera denna nämnda substans.
3. Förfarande för att ästadkomma en antigastrit-substans och/eller en mag-15 särsmotverkande substans enligt patentkrav 2, kännetecknat av, att antigastrit-substansen och/eller den magsärsmotverkande substansen utsöndras i sitt odlingsmedium genom att odla den biologiskt rena Lactobacillus johnsonii -stammen CNCM 1-1225 i nämnda odlingsmedium. 20
4. Förfarande enligt patentkrav 2 eller 3, kännetecknat av, att supernatant- fasen separeras frän nämnda odlingsmedium med konventionella medel efter det att den biologiskt rena Lactobacillus johnsonii -stammen CNCM 1-1225 enligt patentkrav 2 eller 3 har odlats i nämnda odlingsmedium. 25
5. Förfarande enligt nägot av patentkraven 2-4, kännetecknat av, att nämnda antigastrit-substans och/eller magsärsmotverkande substans isoleras genom extrahering frän supernatantfasen enligt patentkrav 4.
6. Förfarande för framställning av en livsmedelssammansättning, känne-30 tecknat av, att en biologiskt ren odling av en mjölksyrabakteriestam, vilken mjölksyrabakteriestam har förmägan attförtränga Helicobacter pylori frän 111382 tarm- eller magceller, eller en sädan mjölksyrabakteriestams odlingssuperna-tant eller frän odlingssupernatanten extraherad substans, varvid nämnda odlingssupernatant eller nämnda extraherade substans har förmägan att för-tränga Helicobacter pylori frän tarm- eller magceller, förenas med en ätbar 5 bärare, varvid nämnda livsmedelssammansättning erhälls.
7. Förfarande för framställning av en läkemedelssammansättning, känne-tecknat av, att en biologiskt ren odling av en mjölksyrabakteriestam, vilken mjölksyrabakteriestam har förmägan att förtränga Helicobacter pylori frän 10 tarm- eller magceller, eller en sädan mjölksyrabakteriestams odlingssupernatant eller frän odlingssupernatanten extraherad substans, varvid nämnda odlingssupernatant eller nämnda extraherade substans har förmägan att förtränga Helicobacter pylori frän tarm- eller magceller, förenas med en ätbar bärare, varvid nämnda läkemedelssammansättning erhälls. 15
8. Förfarande enligt patentkrav 6 eller 7, kännetecknat av, att en Lactobacillus johnsonii-stam CNCM 1-1225 väljs som mjölksyrabakteriestam.
9. Förfarande enligt nägot av patentkraven 6-8, kännetecknat av, att den 20 ätbara bäraren är en farmaceutiskt godtagbar bärare och/eller ett livsmedel säsom surgjord mjölk, speciellt yoghurt eller mjölkbaserad pulverformulering.
FI933001A 1992-07-06 1993-06-30 Förfaranden för åstadkommande av antigastrit-substans och biologiskt ren odling av en mjölksyrabakteriestam samt förfaranden för framställning av livsmedelssammansättning och läkemedelssammansättning FI111382B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92810515A EP0577903B1 (fr) 1992-07-06 1992-07-06 Agent antigastrite
EP92810515 1992-07-06

Publications (3)

Publication Number Publication Date
FI933001A0 FI933001A0 (fi) 1993-06-30
FI933001A FI933001A (fi) 1994-01-07
FI111382B true FI111382B (sv) 2003-07-15

Family

ID=8211947

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933001A FI111382B (sv) 1992-07-06 1993-06-30 Förfaranden för åstadkommande av antigastrit-substans och biologiskt ren odling av en mjölksyrabakteriestam samt förfaranden för framställning av livsmedelssammansättning och läkemedelssammansättning

Country Status (20)

Country Link
US (1) US5578302A (sv)
EP (1) EP0577903B1 (sv)
JP (1) JP2672247B2 (sv)
AT (1) ATE161181T1 (sv)
AU (1) AU668397B2 (sv)
CA (1) CA2099855C (sv)
CZ (1) CZ284196B6 (sv)
DE (1) DE69223615T2 (sv)
DK (1) DK0577903T3 (sv)
ES (1) ES2111625T3 (sv)
FI (1) FI111382B (sv)
GR (1) GR3025971T3 (sv)
HU (1) HU218350B (sv)
IE (1) IE930481A1 (sv)
NO (1) NO307984B1 (sv)
NZ (1) NZ248056A (sv)
PL (1) PL178193B1 (sv)
RO (1) RO117832B1 (sv)
RU (1) RU2129431C1 (sv)
SK (1) SK280661B6 (sv)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
FI104465B (sv) * 1995-06-14 2000-02-15 Valio Oy Proteinhydrolysat för behandling och förebyggande av allergier samt framställning och användning av dessa
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
EP1728855A1 (en) * 1996-11-29 2006-12-06 Bio-K Plus International, Inc. Lactic ferment comprising a particular strain of lactobacillus acidopuilus and use thereof
WO1998023727A1 (en) * 1996-11-29 1998-06-04 Bio K + International Inc. Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
DE69712915T2 (de) * 1996-12-23 2002-09-12 Societe Des Produits Nestle S.A., Vevey Quark
JP3430853B2 (ja) 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
WO1999002042A2 (fr) 1997-07-05 1999-01-21 Societe Des Produits Nestle S.A. Dessert congele contenant des bacteries lactiques et des fibres fermentescibles
WO1999049876A2 (en) * 1998-03-31 1999-10-07 Abbott Laboratories Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
FR2785190B1 (fr) * 1998-10-30 2001-01-26 Lacteol Du Docteur Boucard Lab Composition anti-bacterienne
IL145080A0 (en) 1999-03-11 2002-06-30 Nestle Sa Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
JP3046303B1 (ja) 1999-06-24 2000-05-29 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性飲食品
CA2378426C (en) 1999-08-05 2010-03-23 Societe Des Produits Nestle S.A. Bifidobacteria capable of preventing diarrhea
TR200200301T2 (tr) 1999-08-05 2004-12-21 Societe Des Produits Nestle S.A. Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
ATE542434T1 (de) * 2000-01-18 2012-02-15 Nestle Sa Haustierfutterzusammensetzung zur behandlung der helicobacter spezies in haustieren
EP1148064A1 (en) * 2000-04-17 2001-10-24 Vrije Universiteit Brussel Lactobacillus johnsonii bacteriocin, active against Helicobacter pylori
KR100449598B1 (ko) * 2000-12-08 2004-09-18 (주) 피엘바이오 헬리코박터 필로리의 활성을 억제하는 유산균
EP1260227A1 (en) * 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
SE0103695D0 (sv) 2001-11-07 2001-11-07 Thomas Boren A novel non-antibiotic strategy against OGIP infections based on a cereal product
ATE402993T1 (de) 2002-06-28 2008-08-15 Puleva Biotech Sa Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
WO2005079210A2 (en) * 2003-12-04 2005-09-01 Biofilms Strategies, Inc. Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20060115468A1 (en) * 2004-11-26 2006-06-01 Kara Morrison Dietary supplement for treating and preventing gastrointestinal disorders
MX2007012697A (es) 2005-04-13 2008-01-14 Nestec Sa Formula para infantes con probioticos.
BRPI0611492B1 (pt) 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
PL1981516T3 (pl) 2006-01-27 2019-03-29 Dupont Nutrition Biosciences Aps Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
CN101420965B (zh) 2006-02-15 2013-08-07 雀巢产品技术援助有限公司 长双歧杆菌在制备预防和治疗炎症的药物中的用途
MY149913A (en) 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
EP1992351B1 (en) * 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
CA2712207A1 (en) 2008-01-24 2009-07-30 Nestec S.A. Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
PT2265135T (pt) 2008-03-14 2018-02-21 Nestec Sa Mistura simbiótica
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
RU2556124C2 (ru) * 2009-05-11 2015-07-10 Нестек С.А. Lactobacillus johnsonii La1 NСС533 (CNCM 1-1225) И ИММУННЫЕ НАРУШЕНИЯ
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
AU2010329990B2 (en) 2009-12-08 2015-07-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
EP2397145A1 (en) * 2010-06-18 2011-12-21 Nestec S.A. L. johnsonii La1, B. longum NCC2705 and immune disorders
CN104127443B (zh) * 2014-07-25 2017-11-10 吉林省农业科学院 一种植物乳杆菌c88与人参多糖组合物的制备方法
EP4003061B1 (en) 2019-07-23 2024-04-24 FrieslandCampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953609A (en) * 1974-02-06 1976-04-27 Microlife Technics, Inc. Method for the growth restriction of undesirable digestive system bacteria in animals and the establishment of lactobacillus lactis NRRL B-5628
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
JPS62104552A (ja) * 1985-10-31 1987-05-15 Morinaga Milk Ind Co Ltd 飼料組成物
US4980164A (en) * 1986-10-02 1990-12-25 Bio Techniques Laboratories, Inc. Strains of lactobacillus for enhancing feed conversion efficiency
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US4921857A (en) * 1987-09-18 1990-05-01 Merck & Co., Inc. 4-Oxo-4h-quinolizine-3-carboxylic acids and derivatives thereof
DK686187D0 (da) * 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
SE465206B (sv) * 1989-12-22 1991-08-12 Eva Grahn Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
US5116821A (en) * 1990-11-20 1992-05-26 The Procter & Gamble Company Sulfated glyceroglucolipids as inhibitors of bacterial adherence
US5229380A (en) * 1991-06-28 1993-07-20 Harris Richard Y Method for treating helicobacter pylori gastritis
US5256425A (en) * 1991-08-19 1993-10-26 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
JPH0559038A (ja) * 1991-09-06 1993-03-09 Terumo Corp チオウレア誘導体及びこれを含有する医薬製剤

Also Published As

Publication number Publication date
FI933001A (fi) 1994-01-07
US5578302A (en) 1996-11-26
CA2099855A1 (en) 1994-01-07
EP0577903A1 (fr) 1994-01-12
JP2672247B2 (ja) 1997-11-05
EP0577903B1 (fr) 1997-12-17
SK280661B6 (sk) 2000-05-16
GR3025971T3 (en) 1998-04-30
CZ284196B6 (cs) 1998-09-16
SK71193A3 (en) 1994-06-08
JPH0698782A (ja) 1994-04-12
HUT66632A (en) 1994-12-28
FI933001A0 (fi) 1993-06-30
IE930481A1 (en) 1994-01-12
CA2099855C (en) 1999-06-15
DE69223615D1 (de) 1998-01-29
AU668397B2 (en) 1996-05-02
CZ134293A3 (en) 1994-01-19
ATE161181T1 (de) 1998-01-15
RU2129431C1 (ru) 1999-04-27
ES2111625T3 (es) 1998-03-16
HU9301884D0 (en) 1993-10-28
RO117832B1 (ro) 2002-08-30
NO307984B1 (no) 2000-07-03
DE69223615T2 (de) 1998-04-09
HU218350B (hu) 2000-08-28
PL299543A1 (en) 1994-02-21
NO932407L (no) 1994-01-07
NZ248056A (en) 1995-08-28
AU4158893A (en) 1994-01-13
NO932407D0 (no) 1993-07-01
DK0577903T3 (da) 1998-04-06
PL178193B1 (pl) 2000-03-31

Similar Documents

Publication Publication Date Title
FI111382B (sv) Förfaranden för åstadkommande av antigastrit-substans och biologiskt ren odling av en mjölksyrabakteriestam samt förfaranden för framställning av livsmedelssammansättning och läkemedelssammansättning
FI111650B (sv) Förfarande för att producera en biologiskt ren odling av mjölksyrabakterier
US7767430B2 (en) Bifidobacteria preventing diarrhea caused by pathogenic bacteria
US4746512A (en) Anticariogenic or antiperiodontitic agent
AU779789B2 (en) Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
Ahn et al. Characterization of Lactobacillus acidophilus isolated from piglets and chicken
US6998119B1 (en) Feed composition containing Bifidobacterium CNCM 1-2168 capable of preventing diarrhea
US20070134220A1 (en) Lactobacillus fermentum strain and uses thereof

Legal Events

Date Code Title Description
MM Patent lapsed